Brief: ABVC Biopharma Submits Vitargus Phase II Study Plan To Australia HREC

ABVC Biopharma

16/06/2022 13:32

June 16 (Reuters) - ABVC Biopharma Inc  ABVC.O :
    * ABVC BIOPHARMA SUBMITTED VITARGUS® PHASE II STUDY PLAN TO
AUSTRALIA HREC
    * ABVC BIOPHARMA  - PHASE II STUDY IS TARGETED TO BEGIN IN
AUGUST
OF 2022 IN BOTH AUSTRALIA AND THAILAND AND IS EXPECTED TO BE
COMPLETED BY END OF 2023

Source text for Eikon:  ID:nGNXbDhBtm 
Further company coverage:  ABVC.O 

 ((Reuters.Briefs@thomsonreuters.com;))